STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT03385928
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 201 participants
- Registry
-
NCT03385928
-
- Other papers using this trial's data
- Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Finland, New Zealand, Taiwan, Vietnam
- Registry status
- Completed
Technical summary
Registry record NCT03385928. Randomized; quadruple masking; primary purpose treatment. Start 2018-03-19 (actual); primary completion 2023-05-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
- Condition
- Intracerebral Haemorrhage
- Intervention (Drug)
- Tranexamic Acid
- Intervention (Drug)
- Normal saline
- Lead sponsor
- Neuroscience Trials Australia
- Collaborator
- The Florey Institute of Neuroscience and Mental Health
Record details
- Record id
cardio:ct-nct03385928- Content hash
1bd8a7124a13ddffc7b2d33f95475abdf03e625ca9e0149194fcd13ce3fd6c13